Novozymes A/S (OTCMKTS:NVZMY) Declares $0.19 Dividend

Novozymes A/S (OTCMKTS:NVZMY) announced a dividend on Thursday, April 11th, NASDAQ reports. Investors of record on Thursday, May 2nd will be given a dividend of 0.1853 per share by the biotechnology company on Monday, May 20th. The ex-dividend date of this dividend is Wednesday, May 1st.

Novozymes A/S Stock Performance

NVZMY opened at $55.75 on Tuesday. The stock has a market cap of $26.11 billion, a P/E ratio of 35.29, a P/E/G ratio of 4.14 and a beta of 0.82. The company has a debt-to-equity ratio of 0.30, a current ratio of 1.30 and a quick ratio of 0.80. The stock’s 50 day simple moving average is $57.31 and its 200 day simple moving average is $53.03. Novozymes A/S has a 1-year low of $38.75 and a 1-year high of $61.86.

Novozymes A/S (OTCMKTS:NVZMY) last issued its quarterly earnings results on Wednesday, January 31st. The biotechnology company reported $0.36 earnings per share for the quarter, missing analysts’ consensus estimates of $0.47 by ($0.11). Novozymes A/S had a return on equity of 21.42% and a net margin of 16.88%. The business had revenue of $664.46 million for the quarter. As a group, equities analysts anticipate that Novozymes A/S will post 1.77 EPS for the current fiscal year.

About Novozymes A/S

Novozymes A/S produces and sells industrial enzymes, microorganisms, and probiotics in Denmark, rest of Europe, North America, Asia Pacific, the Middle East, Africa, Latin America, and internationally. The company offers protein solutions for the food and beverage industry. It also offers industrial hygiene, drain openers, hard surface, medical cleaning, septic tanks, ware washing, and professional laundry services.